FDA Email Spying: Crisis Experts Say Agency Needs To Tell Its Story Better

OIG has launched an investigation of FDA’s pre-market review process after the Office of Special Counsel concluded that two devices approved over the objection of FDA scientists likely pose imminent risk to public.

FDA’s surveillance of employee emails has become a major problem for the agency, and experts in crisis management say the agency needs to tell the story behind the operation in order to bolster its public image.

The monitoring of employee online communications became public a year ago when current and former FDA employees filed suit against...

More from Legal & IP

More from Pink Sheet